“The results of the effectiveness of the EpiVacCorona vaccine will be announced in February.
The effectiveness of the vaccine is made up of its immunological effectiveness and preventive effectiveness, ”RIA Novosti quoted Maksyutov as saying.
He explained that immunological efficacy is based on the production of specific antibodies in the vaccinated, and prophylactic is the protection of the vaccinated against the disease.
Earlier, Rospotrebnadzor said that the immunological effectiveness of the EpiVacCorona vaccine is 100%.